Global In Vitro Diagnostics (IVD) Quality Control Market: Key Trends, Market Share, Growth Drivers 2025-2034

February 04, 2025 06:18 AM GMT | By EIN Presswire
 Global In Vitro Diagnostics (IVD) Quality Control Market: Key Trends, Market Share, Growth Drivers 2025-2034
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, February 4, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

The in vitro diagnostics (IVD) quality control market has experienced significant growth in recent years. It is expected to increase from $1.4 billion in 2024 to $1.49 billion in 2025, with a compound annual growth rate (CAGR) of 6.5%. This growth in the past period can be attributed to factors such as regulatory compliance, the rising prevalence of diseases, an aging population, the expansion of diagnostic laboratories, and growing awareness and demand for precision medicine.

How Big Is the Global In Vitro Diagnostics (IVD) Quality Control Market Expected to Grow, and What Is Its Annual Growth Rate?
The in vitro diagnostics (IVD) quality control market is projected to experience substantial growth in the coming years, reaching $2.09 billion by 2029 at a compound annual growth rate (CAGR) of 8.7%. This growth is driven by advancements in personalized medicine, the expansion of point-of-care testing, the integration of digital health, the adoption of next-generation sequencing (NGS), global health security concerns, and the incorporation of electronic health records (EHR). Key trends during the forecast period include multi-analyte quality control materials, the use of AI and machine learning, on-demand quality control solutions, continuous monitoring with real-time feedback, and the development of portable, user-friendly quality control devices.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=5559&type=smp

What Is Driving the Growth of the In Vitro Diagnostics (IVD) Quality Control Market?
The increasing prevalence of infectious diseases like HIV and cancer is playing a key role in the growth of the in vitro diagnostics quality control market. Infectious diseases are widespread and caused by pathogens such as viruses, bacteria, fungi, or parasites. The rising number of cases of infectious diseases, including HIV and cancer, creates a demand for advanced diagnostic testing products and services to ensure effective treatment. This, in turn, is driving the need for in vitro diagnostics quality control to maintain the accuracy, performance, and reliability of testing equipment and results.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

Which Leading Companies Are Driving The Growth Of The In Vitro Diagnostics (IVD) Quality Control Market Share?
Major companies operating in the in vitro diagnostics (IVD) quality control market include Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., LGC Limited., Abbott Laboratories.
What Are The Key Trends Driving The Growth Of The In Vitro Diagnostics (IVD) Quality Control Market Size?
Rising research and development efforts are influencing the in vitro diagnostics quality control market. Leading companies in the IVD quality control sector are creating innovative products to gain a stronger competitive advantage.

How Is the Global In Vitro Diagnostics (IVD) Quality Control Market Segmented?
The in vitro diagnostics (IVD) quality control market covered in this report is segmented –
1) By Product type: Quality Control Products, Data Management Solutions, Quality Assurance Services
2) By Manufacturer Type: IVD Instrument Manufacturers, Third Party Quality Control Manufacturers
3) By Application: Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation Or Hemostasis, Other Applications
4) By End-Users: Hospitals, Clinical Laboratories, Research And Academic Institutes, Other End Users
Subsegments:
1) By Quality Control Products: Control Materials, Quality Control Kits, Proficiency Testing Samples
2) By Data Management Solutions: Software For Quality Control Management, Data Analysis Tools, Cloud-Based Solutions
3) By Quality Assurance Services: Consulting Services, Training And Education Services, Audit And Compliance Services

The Leading Region in the In Vitro Diagnostics (IVD) Quality Control Market is:
North America was the largest region in the in vitro diagnostics (IVD) quality control market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period.
What Is the In Vitro Diagnostics (IVD) Quality Control Market?
In-vitro diagnostics (IVD) quality control refers to a series of processes that ensure the accuracy, performance, and environmental factors affecting in vitro diagnostic tests, including nucleic acid testing for pathogen detection and healthcare-associated infections (HAIs) like pneumonia, urinary tract infections, and other conditions.

Browse Through More Similar Reports By The Business Research Company:
Diagnostic Enzyme Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report
Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/services-global-market-report
Microbiology Diagnostic Devices And Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

About The Business Research Company
With more than 15000+ reports across 27 industries spanning over 60+ geographies, The Business Research Company has carved a niche in offering comprehensive, data-rich research, and unparalleled insights. With 1,500,000 datasets, detailed secondary research, and exclusive insights from industry experts, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Email us at: [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next